Roche Hldg logo

Roche Hldg

Stock
Stock
ISIN: CH0012032113
Ticker: RO
CH0012032113
RO

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Roche Hldg has so far distributed $13.70 in 2026. The next dividend will be paid on 16.03.2027


$5.03

CHART BY

Frequently asked questions

The market capitalization of Roche Hldg is $358.11B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Roche Hldg is 23.49. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Roche Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $19.16. EPS indicates the company's profitability on a per-share basis.
Currently, 23 analysts cover Roche Hldg's stock, with a consensus target price of $461.62. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Roche Hldg reported a revenue of $75.31B.
Roche Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $27.27B. EBITDA measures the company's overall financial performance.
Roche Hldg has a free cash flow of $18.24B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Roche Hldg employs approximately 112,774 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Roche Hldg is 29.54M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$358.11B
EPS (TTM) 
$19.16
Free Float 
29.54M
P/E ratio (TTM) 
23.49
Revenue (TTM) 
$75.31B
EBITDA (TTM) 
$27.27B
Free Cashflow (TTM) 
$18.24B

Pricing

1D span
$438.44$450.64
52W span
$331.79$495.71

Analyst Ratings

The price target is $461.62 and the stock is covered by 23 analysts.

Buy

12

Hold

9

Sell

2

Information

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Employees
112,774
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
CH0012032113
Primary Ticker
RO

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation